User contributions for Smithsr
From MicrobeWiki, the student-edited microbiology resource
19 December 2014
- 03:2603:26, 19 December 2014 diff hist +11 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Future Research
- 03:2603:26, 19 December 2014 diff hist −16 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Conclusion
- 03:2503:25, 19 December 2014 diff hist +97 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Role of T Follicular Helper Cells in Antibody Development:
- 03:2303:23, 19 December 2014 diff hist +3 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →HIV Antibody Development in a Single Patient
- 03:2003:20, 19 December 2014 diff hist −1 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →HIV Antibody Development in a Single Patient
- 03:2003:20, 19 December 2014 diff hist 0 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Common Mutations in the Structure of Primary Epitopes
- 03:1703:17, 19 December 2014 diff hist −5 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Structures of Primary HIV Antibody Epitopes
- 03:1303:13, 19 December 2014 diff hist +77 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Introduction
17 December 2014
- 05:0405:04, 17 December 2014 diff hist +65 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Role of T Follicular Helper Cells in Antibody Development:
- 05:0305:03, 17 December 2014 diff hist +84 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Development of Broadly Neutralizing Antibodies and the Potential Role of Broadly Neutralizing Antibodies in Vaccine Development
- 05:0105:01, 17 December 2014 diff hist +84 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →HIV Antibody Development in a Single Patient
- 05:0105:01, 17 December 2014 diff hist +85 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Common Mutations in the Structure of Primary Epitopes
- 05:0005:00, 17 December 2014 diff hist +67 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Structures of Primary HIV Antibody Epitopes
- 04:5904:59, 17 December 2014 diff hist −1 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Introduction
- 04:5904:59, 17 December 2014 diff hist +76 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Introduction
- 04:5604:56, 17 December 2014 diff hist +4 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Structures of Primary HIV Antibody Epitopes
- 04:5504:55, 17 December 2014 diff hist +2 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Role of T Follicular Helper Cells in Antibody Development:
- 04:5504:55, 17 December 2014 diff hist +1 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Common Mutations in the Structure of Primary Epitopes
- 04:5504:55, 17 December 2014 diff hist +4 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →Common Mutations in the Structure of Primary Epitopes
- 04:5104:51, 17 December 2014 diff hist +7 The Implications of Broadly Neutralizing Antibody Development and Epitope Targeting for HIV Vaccine Development →HIV Antibody Development in a Single Patient